Drägerwerk stock gains as a September 22 report date nears

Published on 09/08/2026 at 13:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Drägerwerk stock is trading near its recent range as analysts point to margin improvement and investors await the Q2 2026 earnings release on September 22, 2026.

Moderne Intensivstation mit Beatmungsgerät und Patientenmonitoring in klinischer Umgebung — Drägerwerk AG & Co. KGaA zeigt moderne Intensivstation mit Beatmungsgeräten und Patientenmonitoring DE0005550636, Illustration mit AI erstellt.

Drägerwerk stock (ISIN DE0005550636) traded at EUR 110.40 on Börse Stuttgart on September 7, 2026, after a 0.36 percent daily decline and a 60.12 percent gain since January 1. MarketScreener also listed an earnings release for Q2 2026 on September 22, 2026, which keeps the next reporting date in view.

Range stays wide

The same calendar page showed EUR 110.40 as the latest quote and a one-year advance of 60.12 percent, while the alternative German market snapshot in the search results showed EUR 83.00 and a 1.19 percent daily decline on September 7, 2026. That gap underlines how much venue and timestamp matter for Drägerwerk shares.

For investors, the key question is whether the stock can hold the higher part of its 2026 range once the next report lands on September 22, 2026.

Margins are the issue

finanznachrichten.de carried a September 7, 2026 note from Warburg Research saying the broker raised its target price to EUR 130.00 and kept a buy recommendation. The same report said the latest business development supports the view that margins should improve structurally.

That interpretation matters because the stock already reflects a strong year-to-date move of 60.12 percent, so fresh upside now depends more on execution than on multiple expansion alone.

Q2 2026 is next

The calendar entry for September 22, 2026 makes the upcoming Q2 2026 release the most concrete near-term catalyst. If that report confirms the margin story, the market will have a firmer base for the current rally.

Product and business

Drägerwerk's medical and safety technology remains the operating core behind the share story. In the current setup, the market is reading the next earnings release less as a routine event and more as a test of whether the margin recovery is holding.

Price close

Drägerwerk stock last changed hands at EUR 110.40 on September 7, 2026, with the calendar page also showing a 1st Jan change of 60.12 percent. The lower German market snapshot in the search results put the stock at EUR 83.00 on the same day, so the exact reference depends on the venue and timestamp.